SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
28 hedge funds and large institutions have $375M invested in Sinovac Biotech, Ltd in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
Holders
28
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$38.2M | |
| 2 | +$849K | |
| 3 | +$109K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$106K |
| 5 |
Morgan Stanley
New York
|
+$54K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $334M |
|
|||
|
VC
2
Vivo Capital
Palo Alto,
California
| $38.2M |
|
|||
|
NAH
3
Neumann Advisory (HK)
Central,
Hong Kong
| $2.04M |
|
|||
4
Renaissance Technologies
New York
| $849K |
|
|||
5
Wells Fargo
San Francisco,
California
| $109K |
|
|||
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $106K |
|
|||
|
7
Morgan Stanley
New York
| $54K |
|
|||
8
UBS Group
Zurich,
Switzerland
| $14.3K |
|
|||
|
HI
9
Horizon Investments
Charlotte,
North Carolina
| $336 |
|